Cargando…
Curcumin attenuates prostatic hyperplasia caused by inflammation via up-regulation of bone morphogenetic protein and activin membrane-bound inhibitor
CONTEXT: Inflammation and epithelial-mesenchymal transition (EMT) play important roles in the occurrence and development of benign prostatic hyperplasia (BPH); curcumin exerts anti-proliferative, anti-inflammatory, and anti-EMT effects. OBJECTIVE: To explore the anti-inflammatory and anti-EMT mechan...
Autores principales: | Liu, Yuhang, Wang, Zhaohui, Gan, Yu, Chen, Xiang, Zhang, Bo, Chen, Zhi, Liu, Peihuan, Li, Bingsheng, Ru, Feng, He, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354175/ https://www.ncbi.nlm.nih.gov/pubmed/34357837 http://dx.doi.org/10.1080/13880209.2021.1953539 |
Ejemplares similares
-
Combination therapy with curcumin plus tamsulosin and finasteride in the treatment of men with benign prostatic hyperplasia: a single center, randomized control study
por: Qiao, Jing, et al.
Publicado: (2021) -
Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways
por: Wang, Zhaohui, et al.
Publicado: (2020) -
Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors
por: Breen, Michael J., et al.
Publicado: (2013) -
Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling
por: Xie, Chen, et al.
Publicado: (2020) -
Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia.
por: Bentley, H., et al.
Publicado: (1992)